Metastatic melanoma vs lymphoma. Using a sentinel lymph node biopsy a diagnostic tool

Area of Science:

• Oncology
• Dermatology
• Hematology

Background:

• Sentinel lymph node biopsy (SLNB) is a standard prognostic tool for melanoma (stage IB+).
• Clinical lymphadenopathy typically contraindicates SLNB, favoring primary lymph node dissection.
• Current guidelines recommend regional lymphatic tissue dissection for melanoma with clinical lymphadenopathy.

Observation:

• This case involves a patient with stage II melanoma and concurrent B cell lymphoma with widespread lymphadenopathy.
• The multidisciplinary team considered SLNB as a diagnostic option.
• The patient presented with clinical uncertainty due to the dual diagnosis.

Findings:

• SLNB was deemed more informative than ultrasonography and fine needle aspiration for this complex case.
• Cytology alone is insufficient for determining lymphoma grade and subtype due to lack of nodal morphology.
• Histological architecture is crucial for accurate lymphoma subtyping and grading.

Implications:

• SLNB can be a valuable tool in complex cases of dual melanoma and lymphoma diagnoses.
• This approach provides essential histological detail for accurate diagnosis and treatment planning.
• Further research may clarify the role of SLNB in managing patients with concurrent malignancies.